US · NTHI
Neonc Technologies Holdings, Inc.
- Sector
- Healthcare · Biotechnology
- Headquarters
- Calabasas, CA 90069
- Website
- neonctech.com
Price · as of 2026-07-02
$4.42
Market cap 93.78M
Price history
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | |||||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $0.00 | $0.00 |
Line items
Line items
Line items
About Neonc Technologies Holdings, Inc.
Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
- CEO
- Amir Farrokh Heshmatpour
- Employees
- 8
- Beta
- 0.19
Peer comparison
Same-industry comparables, ranked by market cap.
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | Model Valuation | Core Valuation | Growth | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | Sales Growth |
| NTHI | Neonc Technologies Holdin… | $4.42 | 93.78M | — | — | — | — | — | — | — | — | 1779.00% |
| CDXS | Codexis, Inc. | $2.15 | 172.62M | — | — | — | — | — | — | — | — | — |
| GNFT | Genfit S.A. | $3.89 | 193.71M | +1,565% | -38% | -54% | +23% | 103.96 | 2.26 | 2.34 | 16.42 | 13456.00% |
| IVA | Inventiva S.A. | $4.10 | 213.13M | — | — | — | +2,015% | — | — | — | — | — |
| IVVD | Invivyd, Inc. | $1.52 | 182.32M | — | — | — | — | — | — | — | — | — |
| MDWD | MediWound Ltd. | $18.15 | 197.42M | — | — | — | -15% | — | — | — | — | — |
| OABI | OmniAb, Inc. | $1.43 | 174.93M | — | — | — | +692% | — | — | — | — | — |
| OBIO | Orchestra BioMed Holdings… | $3.92 | 211.5M | — | — | — | — | — | — | — | — | — |
| SLS | SELLAS Life Sciences Grou… | $1.68 | 177.08M | — | — | — | — | -2.36 | 7.69 | — | 94.85 | — |
| TARA | Protara Therapeutics, Inc… | $4.44 | 171.3M | — | — | — | — | -1.86 | 0.50 | — | 1.70 | — |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $4.42) − 1 = — (DCF, example).